How does the empiric pharmacological therapy differ in a patient with healthcare
How does the empiric pharmacological therapy differ in a patient with healthcare-associated meningitis (such as a neurosurgical patient with an external ventricular drain) as compared to a healthy adult with community-acquired bacterial meningitis? Explain your rationale. According to the 2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-associated ventriculitis and meningitis, healthcare-associated meningitis/ventriculitis […]